P&G v. Amway
This article was originally published in The Tan Sheet
Executive Summary
Houston federal judge Vanessa Gilmore rules P&G's Lanham Act claim that multi-level marketer disparaged Crest toothpaste is barred by Salt Lake City federal judge's earlier decision denying P&G's request to add product disparagement claims in a parallel lawsuit against Amway. In a Jan. 8 opinion, Gilmore also finds remaining P&G claims alleging Amway circulated false rumors that consumer products giant was associated with Satanism are similarly barred by res judicata effect of the Utah court's rulings, which were upheld by a Denver appeals court Jan. 6. P&G says it is "disappointed" in the rulings; Amway says court decisions end P&G's litigation against the company related to the Satanism rumors, with two cases still pending against Amway distributors...
You may also be interested in...
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.